483 K.C. Pharmaceuticals May 2014

483 K.C. Pharmaceuticals May 2014

Cassandra Abellard FDA, Uttaniti Limchumroon FDA, Arie Menachem FDA$119.00 - Available Now

FDA investigators audited the K.C. Pharmaceuticals - Pomona, CA, United States facility and issued inspectional observations (via FDA 483) on 23 May 2014.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 23 May 2014
  • Location: Pomona, United States
  • FEI: 2026940
Add To Cart